Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Iyuzeh™ (latanoprost) – New drug approval
December 14, 2022 - Thea Pharma announced the FDA approval of Iyuzeh (latanoprost), for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
